Windlass Healthcare Limited (WHC), promoted by Shri Ashok Windlass and his sons, Hitesh Windlass and Manoj Windlass, was established in 2008. Their vision of establishing an excellent manufacturing facility that caters primarily to regulated markets resulted in Windlass Healthcare with its corporate headquarters in Gurgaon.
In the span of just five years, our company completed US FDA audit. By 2014 climbing the ladder of success further, we had developed and filed four Abbriated New Drug Applications (ANDA's) in US. Three of these were the FTF opportunities (First to file) with a possibility of a day-1 launch and 180 days exclusivity. Apart from our strong research and development policies, we have secure financial fundamentals, which is one of the main reason for the trust placed in us by our private investors. Therefore, we are able to form effective partnerships with pharmaceutical giants wanting to outsource their manufacturing processes.
Our own manufacturing facilities are designed as per the US Food and Drug Administration (US FDA), and European Union current Good Manufacturing Practices (EU cGMP) standards. We research, develop, and market pharmaceutical products and formulations manufactured using proprietary technology and intellect, in various markets across the world.
With a highly experienced leadership and a team of 300 talented professional, we plan to expand our regulated markets to US, Europe, Australia, South Africa, and Latin America to become an eminent presence in the global pharmaceutical scenario.
Our rich legacy of 60 years and our vast experience in multiple domains enable us to uphold our core belief – adhering to high quality standards while manufacturing. Our international benchmarks for manufacturing combined with periodic inspections by reputed regulatory agencies like FDA, ensure our products meet our commitment towards patients, caregivers and society as a whole.